Fertisalus


.

Looking to learn more about the China In Vitro Fertilization market? Check out our latest report for forecast details and treatment insights.

China In Vitro Fertilization market – By Treatment, Forecast 2019-2025

The China in vitro fertilization (IVF) market is expected to register a CAGR of over 14%, during the forecast period, 2019-2025. The major factors driving the market are rising incidence of infertility, technological advancement, and increasing government support.

According to the National Health Commission of the People’s Republic of China, in 2016, around 10% of married Chinese couples were affected by infertility. The IVF procedure comprises of different stages, including ovarian stimulation, egg retrieval, fertilization, embryo transfer, and cryopreservation.

The market is segmented by treatment into intracytoplasmic sperm injection (ICSI), conventional IVF, minimal stimulation IVF, and natural cycle IVF. The conventional IVF segment is further divided into IVF with ovarian hyperstimulation, IVF without ovarian hyperstimulation, and intracytoplasmic sperm injection (ICSI). The minimal stimulation IVF is further classified into microdose gonadotropin and natural cycle IVF.

The market is further segmented by cycle type into fresh IVF cycle and frozen IVF cycle. The fresh IVF cycle is anticipated to hold the largest market share, due to the high success rates associated with this cycle type.

The market is further segmented by end user into fertility clinics, hospitals, and other end users. The fertility clinics segment is further divided into standalone fertility clinics and integrated fertility clinics. The standalone fertility clinics segment is anticipated to hold the largest market share, due to the presence of a large number of such clinics.

Geographically, the market is segmented into five major regions, namely, North China, East China, South China, Central China, and Northwest China.

Some of the prominent players in the China IVF market are BGI, Fujian Tulonghua Human Reproduction Technology Co. Ltd., Hefei Anhui Fertility Clinic, Nanjing Jinling Hospital, and Beijing Obstetrics and Gynecology Hospital.

Chinese economic development has been a significant factor in determining the shift of Chinese families to In-Vitro fertilization (IVF) when it comes to parenthood. The introduction of China’s two-child policy in October 2015, Chinese women’s desire to have the opportunity to focus on their careers first and later in their lives on pregnancy, or to have a child even as single parents, are all key factors behind the growing demand for IVF services in China. China In Vitro Fertilization market is expected to be more than US$ 2.8 Billion by 2025.

Access full Research:

renub.com/china-in-vitro-…

Because of financial advancement and globalization, the lifestyle of the urban Chinese family has altered. Most females delay marriage and have kids, which makes it more difficult for couples to naturally conceive. Besides, it has been revealed that men now have a substantial decrease in sperm count in high-density urban regions due to high rates of stress and pollution. It is worth noting that China’s average marriage age was 23 in the 1970s, 24 in the 1990s, and the 21st century it has risen to 27.

In the last few years, the demand for Assisted Reproductive Techniques (ART) has grown many folds. The primary cause of the rise in ARTS is infertility among patients. ARTS is triggering due to fast lifestyle change, smoking, drinking, steroids, mental stress/trauma, and other medical conditions such as diabetes, cystic fibrosis, trauma, testicular failure, and Fallopian blockage of the tube, female ovarian dysfunction, etc. These variables, therefore, are supporting the China IVF market growth and development.

Global healthcare firms are the major IVF services firms in China. These firms have a “passive” company model, although they integrate relationships with tour agents and referral offices. Tapping into this increasing demand for IVF services in China has become a significant chance for overseas firms to explore fresh markets in medical care.

Renub Research report titled “China In Vitro Fertilization Market, (IVF) by Treatment (Fresh Embryo, Frozen Embryo, Donor Egg, Others), Instruments (Culture Media, Disposable Devices, Capital Equipment), Procedure (ICSI IVF, Non-ICSI IVF, IUI), End-User (Fertility Clinics, Hospitals, Others)” provides a complete analysis of China In Vitro Fertilization (IVF) Market.

Request a free Sample copy of the report:

renub.com/request-sample-…

Treatment – China In-Vitro Fertilization (IVF) Market is divided into 4 segments

• Fresh Embryo

• Frozen Embryo

• Donor Egg

• Others

Instruments – Culture Media is leading Instruments in the China In-Vitro Fertilization (IVF) Market

Based on instruments, China In-Vitro Fertilization (IVF) market is segmented into

• Culture Media

• Disposable Devices

• Capital Equipment



Procedures – In this report, we have categorized the China In-Vitro Fertilization (IVF) market into three procedures

• ICSI IVF

• Non-ICSI IVF

• IUI.

Request a free Brochure copy of the report:

renub.com/request-brochur…

End-User – has been categorized into three types

• Fertility Clinics

• Hospitals

• Others

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Contact Us

Email: info@renub.com

Phone: +1-678-302-0700

Web: renub.com